[A clinical trial with the monophasic contraceptive Marvelon].
The authors present their clinical experience with a monophasic preparation consisting of 30 mcg ethynyl estradiol and 150 mcg desogestrel (Marvelon, Organon). 121 cycles of 24 fertile women were followed. The results show a full contraceptive success, a stable cycle control as well as a low incidence of the side effects.
Rachev
E
E
Damianov
L
L
Katsarova
M
M
D000293:Adolescent; D000328:Adult; D017135:Desogestrel / Q000009:adverse effects; D005260:Female; D006801:Humans; D008597:Menstrual Cycle / Q000187:drug effects; D013997:Time Factors
D017135:Desogestrel
Klinichen opit s monofazen kontratseptiv--Marvelon.